SCHEMBL29573781

SCHEMBL29573781

O[C@H]1[C@H](n2cnc3c(NCC(F)F)nc(Cl)nc32)[C@H]2C[C@@]2(CF)[C@H]1O

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 19/20 0.73
▸ ADORA1 P30542 12/20 0.73
▸ ADORA3 P0DMS8 10/20 0.73
▸ HTR2C P28335 16/20 0.70
▸ SLC6A3 Q01959 4/20 0.70
▸ HTR1D P28221 2/20 0.69
▸ ADRA2B P18089 1/20 0.69
▸ TMIGD3 P0DMS9 5/20 0.61
▸ ADORA2A P29274 5/20 0.61
▸ TSPO P30536 2/20 0.59
▸ HRH2 P25021 1/20 0.59
▸ TMEM97 Q5BJF2 1/20 0.59
▸ ADRA2C P18825 1/20 0.59
▸ HTR2A P28223 1/20 0.59
▸ OPRM1 P35372 1/20 0.59
▸ CHRM3 P20309 1/20 0.59
▸ ADRB3 P13945 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29574436 0.86 ADORA1 (0.57) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL31350109 0.84 HTR2B (1.00) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL31350184 0.83 HTR2B (1.00) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL29574073 0.82 HTR2B (0.51) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL31350110 0.82 HTR2B (1.00) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL29573308 0.79 ADORA3 (0.78) HTR2BADORA1ADORA3HTR2CTMIGD3
SCHEMBL19464941 0.77 HTR2B (1.00) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL19464867 0.77 HTR2B (1.00) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL19464934 0.77 HTR2B (1.00) HTR2BADORA1ADORA3HTR2CSLC6A3
SCHEMBL29573470 0.76 ADORA3 (0.62) HTR2BADORA1ADORA3HTR2CSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457356-A A3 adenosine receptor agonists for use in medicine 生物干预公司 2023-07-18 — — CN disclosed
EP-4196219-A1 A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE Biointervene, Inc. (US) 2023-06-21 — — EP disclosed
WO-2022040241-A1 A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE BIOINTERVENE, INC. (US) 2022-02-24 — — WO disclosed
Send feedback